Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, et al. Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society. Hum Reprod Update. 2014;20(3):334–52.
Article CAS PubMed Google Scholar
Murphy MK, Hall JE, Adams JM, Lee H, Welt CK. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(10):3878–84.
Article CAS PubMed Google Scholar
Meczekalski B, Niwczyk O, Kostrzak A, Maciejewska-Jeske M, Bala G, Szeliga A. PCOS in adolescents-ongoing riddles in diagnosis and treatment. J Clin Med. 2023;12(3):1221.
Article CAS PubMed PubMed Central Google Scholar
Fruh V, Cheng JJ, Aschengrau A, Mahalingaiah S, Lane KJ. Fine particulate matter and polycystic ovarian morphology. Environ Health. 2022;21(1):1–8.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.
Gao X-Y, Liu Y, Lv Y, Huang T, Lu G, Liu H-B, et al. Role of androgen receptor for reconsidering the “true” polycystic ovarian morphology in PCOS. Sci Rep. 2020;10(1):1–7.
Merino PM, Villarroel C, Jesam C, López P, Codner E. New diagnostic criteria of polycystic ovarian morphology for adolescents: impact on prevalence and hormonal profile. Horm Res Paediatr. 2017;88:401–7.
Article CAS PubMed Google Scholar
Codner E, Villarroel C, Eyzaguirre FC, López P, Merino PM, Pérez-Bravo F, et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril. 2011;95(2):702-6.e2.
Sum-Yee C, Victor W. Difficulties in diagnosing polycystic ovarian syndrome in adolescents: a narrative review. Hong Kong J Gynaecol Obstet Midwifery. 2022;22(1):33.
Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril. 2009;92(2):626–34.
Article CAS PubMed Google Scholar
Silva JF, Ocarino NM, Serakides R. Thyroid hormones and female reproduction†. Biol Reprod. 2018;99(5):907–21.
Cai J, Zhang Y, Wang Y, Li S, Wang L, Zheng J, et al. High thyroid stimulating hormone level is associated with hyperandrogenism in euthyroid polycystic ovary syndrome (PCOS) women, independent of age, BMI, and thyroid autoimmunity: a cross-sectional analysis. Front Endocrinol. 2019;10:222.
Xu S, Zhang Y, Qiang C, Zhang C. Effect of TSH on oocyte maturation of PCOS patients with normal thyroid function in IVF. Reprod Biol Endocrinol. 2022;20(1):1–8.
Garcia-Beltran C, Bassols J, Carreras-Badosa G, Bermejo AL, Ibáñez L, de Zegher F. Raised thyroid stimulating hormone in girls with polycystic ovary syndrome: effects of randomized interventions. Horm Res Paediatr. 2023. https://doi.org/10.1159/000529183.
Tagliaferri V, Romualdi D, Guido M, Mancini A, De Cicco S, Di Florio C, et al. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic–hyperinsulinaemic clamp study. Eur J Endocrinol. 2016;175(5):433–41.
Article CAS PubMed Google Scholar
Rojhani E, Rahmati M, Firouzi F, Naz MSG, Azizi F, Tehrani FR. Polycystic ovary syndrome, subclinical hypothyroidism, the cut-off value of thyroid stimulating hormone; is there a link? Findings of a population-based study. Diagnostics. 2023;13(2):316.
Article CAS PubMed PubMed Central Google Scholar
Mitkov M, Nyagolova P, Orbetzova M. Thyroid stimulating hormone levels in euthyroid women with polycystic ovary syndrome. Akush Ginekol. 2015;54(6):10–5.
Yu Q, Wang J-B. Subclinical hypothyroidism in PCOS: impact on presentation, insulin resistance, and cardiovascular risk. BioMed Res Int. 2016;2016:1–7.
Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9(1):1–7.
Rashidi H, Tehrani FR, Khomami MB, Tohidi M, Azizi F. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol. 2014;174:100–5.
Zadeh-Vakili A, Tehrani FR, Hosseinpanah F. Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetol Metab Syndr. 2011;3:18.
Article PubMed PubMed Central Google Scholar
Amouzegar A, Delshad H, Mehran L, Tohidi M, Khafaji F, Azizi F. Reference limit of thyrotropin (TSH) and free thyroxine (FT 4) in thyroperoxidase positive and negative subjects: a population based study. J Endocrinol Invest. 2013;36:950–4.
Maraka S, Ospina NM, O’Keeffe DT, De Ycaza AEE, Gionfriddo MR, Erwin PJ, et al. Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid : Off J Am Thyroid Assoc. 2016;26(4):580–90.
Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140(7):815–30.
Article CAS PubMed Google Scholar
Harding M, Lamarche C. A quantile regression approach for estimating panel data models using instrumental variables. Econ Lett. 2009;104(3):133–5.
Thyroid Disease in Pregnancy. ACOG Practice Bulletin, Number 223. Obstet Gynecol. 2020;135(6):e261–74.
Zeber-Lubecka N, Hennig EE. Genetic susceptibility to joint occurrence of polycystic ovary syndrome and Hashimoto’s thyroiditis: how far is our understanding? Front Immunol. 2021;12:606620.
Article CAS PubMed PubMed Central Google Scholar
Mariya A, Qaiser J. Thyroid dysfunction: In connection with PCOS. In: Zhengchao W, editor. Polycystic ovary syndrome. Rijeka: IntechOpen; 2022. p. Ch. 2.
Calvar CE, Bengolea SV, Deutsch SI, Hermes R, Ramos G, Loyato M. High frequency of thyroid abnormalities in polycystic ovary syndrome. Medicina. 2015;75(4):213–7.
Singla R, Gupta Y, Khemani M, Aggarwal S. Thyroid disorders and polycystic ovary syndrome: an emerging relationship. Indian J Endocrinol Metab. 2015;19(1):25–9.
Article PubMed PubMed Central Google Scholar
van der Ham K, Stekelenburg KJ, Louwers YV, van Dorp W, Schreurs MW, van der Wal R, et al. The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS. Front Endocrinol. 2023;14:1245106.
Zhao Z, Gao Y, Pei X, Wang W, Wang R, Zhang H. Thyroid function and polycystic ovary syndrome: a Mendelian randomization study. Front Endocrinol. 2024;15:1364157.
Zhang B, Wang J, Shen S, Liu J, Sun J, Gu T, et al. Subclinical hypothyroidism is not a risk factor for polycystic ovary syndrome in obese women of reproductive age. Gynecol Endocrinol. 2018;34(10):875–9.
Lee HJ, Jo HN, Noh HK, Kim SH, Joo JK. Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome? Ginekol Pol. 2023;94(3):203–10.
Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid : Off J Am Thyroid Assoc. 2017;27(3):315–89.
Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S. Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene. Indian J Endocrinol Metab. 2019;23(3):326–31.
Article CAS PubMed PubMed Central Google Scholar
Franks S, Hardy K. Androgen action in the ovary. Front Endocrinol. 2018;9:404005.
Gervásio CG, Bernuci MP, de Sá MFS, de Sá-Rosa-e-Silva ACJ. The role of androgen hormones in early follicular development. Int Sch Res Not. 2014;2014(1):818010.
留言 (0)